Get the Stockscreener App
2.42
0.00%
0.00
After Hours:
2.42
Collplant Biotechnologies Ltd Stock (CLGN) Forecast
The Collplant Biotechnologies Ltd (CLGN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $10.55, representing a +336.03% increase from the current price of $2.42. The highest analyst price target is $12.41, and the lowest is $8.696.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CLGN Price Target
Average 15.84
(+554.51% Upside)
Is Collplant Biotechnologies Ltd (CLGN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 28.97 | Buy |
| STOCH(9,6) | 60.76 | Neutral |
| STOCHRSI(14) | 75.38 | Neutral |
| MACD(12,26) | -0.1909 | Buy |
| ADX(14) | 17.53 | Neutral |
| William %R | -69.08 | Neutral |
| CCI(14) | -8.6085 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.4412
Sell
|
2.4717
Sell
|
| MA20 |
2.5752
Sell
|
2.6009
Sell
|
| MA50 |
3.0577
Sell
|
2.9724
Sell
|
| MA100 |
3.4972
Sell
|
3.3884
Sell
|
| MA200 |
4.0792
Sell
|
3.9424
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CLGN could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on CLGN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.97 indicates that CLGN is oversold. This indicates that CLGN price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 60.76 indicates that CLGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 75.38 indicates that CLGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.53 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -8.6085 indicates that CLGN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CLGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Collplant Biotechnologies Ltd financial reports and earnings history, Collplant Biotechnologies Ltd (CLGN) stock could reach $7.3125 by 2030, $9.9832 by 2040 and $15.85 by 2050. See the projected annual prices until 2050 of the Collplant Biotechnologies Ltd stock below:
- Collplant Biotechnologies Ltd (CLGN) is expected to reach an average price of $7.7241 in 2035, with a high prediction of $8.2022 and a low estimate of $6.5216. This indicates an $219.18% rise from the last recorded price of $2.42.
- Collplant Biotechnologies Ltd (CLGN) stock is projected to chart a bullish course in 2040, with an average price target of $9.1046, representing an $276.22% surge from its current level. The forecast ranges from a conservative $9.0537 to a sky-high $9.9832.
- Our analysts predict Collplant Biotechnologies Ltd (CLGN) to jump 297.33% by 2045, soaring from $9.1442 to an average price of $9.6155, potentially reaching $11.95. While $9.1442 is the low estimate, the potential upside is significant.
- Collplant Biotechnologies Ltd (CLGN) stock is expected to climb by 2050, reaching an average of $15.47, a $539.09% jump from its current level. However, a wide range of estimates exists, with high and low targets of $15.85 and $12.26, respectively, highlighting the market's uncertainty.
Collplant Biotechnologies Ltd Stock (CLGN) Year by Year Forecast
Collplant Biotechnologies Ltd Stock (CLGN) Price Forecast for 2025
Collplant Biotechnologies Ltd Stock (CLGN) is expected to reach an average price of $10.43 in 2025, with a high prediction of $15.24 and a low estimate of $5.6205. This indicates an +331.08% rise from the last recorded price of $2.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $11.95 | $8.696 | $12.41 | +393.68% |
| June, 2025 | $11.73 | $10.50 | $12.95 | +384.64% |
| July, 2025 | $10.72 | $10.45 | $11.50 | +342.96% |
| August, 2025 | $9.711 | $9.711 | $10.92 | +301.28% |
| September, 2025 | $10.19 | $9.5616 | $10.55 | +321.17% |
| October, 2025 | $9.8537 | $9.5028 | $10.20 | +307.18% |
| November, 2025 | $9.045 | $8.228 | $9.8541 | +273.76% |
| December, 2025 | $7.6815 | $7.4562 | $9.3073 | +217.42% |
Collplant Biotechnologies Ltd Stock (CLGN) Price Forecast for 2026
The predicted value for Collplant Biotechnologies Ltd (CLGN) in 2026 is set at an average of $15.84. Estimates vary from a peak of $24.97 to a trough of $6.7068, indicating an +554.51% surge from the present price of $2.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.5603 | $6.7068 | $9.1474 | +253.73% |
| February, 2026 | $9.369 | $8.6281 | $12.31 | +287.15% |
| March, 2026 | $16.47 | $9.5393 | $17.03 | +580.59% |
| April, 2026 | $19.75 | $13.84 | $24.97 | +716.19% |
| May, 2026 | $13.43 | $12.12 | $20.00 | +455.08% |
| June, 2026 | $14.51 | $11.35 | $14.63 | +499.76% |
| July, 2026 | $14.72 | $13.04 | $15.72 | +508.09% |
| August, 2026 | $17.59 | $14.24 | $19.60 | +626.74% |
| September, 2026 | $20.78 | $17.69 | $24.21 | +758.62% |
| October, 2026 | $19.14 | $17.45 | $21.47 | +691.01% |
| November, 2026 | $18.12 | $16.72 | $21.38 | +648.80% |
| December, 2026 | $17.62 | $16.57 | $19.22 | +628.20% |
Collplant Biotechnologies Ltd Stock (CLGN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Collplant Biotechnologies Ltd (CLGN) is $15.49, with a high forecast of $23.73 and a low forecast of $7.248. This indicates an +539.94% increase from the last price of $2.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.38 | $16.39 | $21.93 | +783.63% |
| February, 2027 | $19.67 | $19.25 | $23.73 | +712.60% |
| March, 2027 | $13.52 | $12.33 | $20.72 | +458.54% |
| April, 2027 | $12.44 | $12.25 | $19.03 | +413.96% |
| May, 2027 | $10.50 | $9.4884 | $13.02 | +334.05% |
| June, 2027 | $10.46 | $9.8496 | $12.73 | +332.26% |
| July, 2027 | $11.95 | $9.3312 | $15.50 | +393.88% |
| August, 2027 | $9.983 | $9.7905 | $12.44 | +312.52% |
| September, 2027 | $10.24 | $8.2343 | $11.30 | +323.33% |
| October, 2027 | $9.0858 | $8.3758 | $10.24 | +275.45% |
| November, 2027 | $9.2471 | $8.4964 | $9.7236 | +282.11% |
| December, 2027 | $10.61 | $7.248 | $10.61 | +338.37% |
Collplant Biotechnologies Ltd Stock (CLGN) Price Forecast for 2028
In 2028, Collplant Biotechnologies Ltd (CLGN) is projected to reach an average price of $9.8655, with a high projection of $14.72 and a low estimate of $5.0138. This indicates an +307.67% rise from the last price of $2.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $8.6048 | $7.7398 | $10.73 | +255.57% |
| February, 2028 | $7.5411 | $6.9211 | $9.7303 | +211.61% |
| March, 2028 | $7.0026 | $6.9624 | $8.3517 | +189.36% |
| April, 2028 | $5.4538 | $5.0138 | $7.7429 | +125.37% |
| May, 2028 | $9.0854 | $5.3141 | $11.20 | +275.43% |
| June, 2028 | $10.80 | $8.4214 | $11.33 | +346.14% |
| July, 2028 | $12.74 | $10.27 | $14.72 | +426.36% |
| August, 2028 | $9.6994 | $8.7594 | $13.03 | +300.80% |
| September, 2028 | $7.8506 | $7.2503 | $9.7497 | +224.41% |
| October, 2028 | $7.5725 | $7.5512 | $8.4813 | +212.91% |
| November, 2028 | $8.1234 | $7.0625 | $8.7531 | +235.68% |
| December, 2028 | $8.9146 | $7.9537 | $9.6546 | +268.37% |
Collplant Biotechnologies Ltd Stock (CLGN) Price Forecast for 2029
The 2029 price forecast for Collplant Biotechnologies Ltd Stock (CLGN) is $7.0213 on average, with a high prediction of $9.0549 and a low estimate of $4.9876. This represents an +190.13% increase from the previous price of $2.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.0262 | $6.6859 | $9.0549 | +190.34% |
| February, 2029 | $7.7974 | $6.7997 | $8.6374 | +222.21% |
| March, 2029 | $7.6086 | $7.0577 | $8.5982 | +214.41% |
| April, 2029 | $5.9299 | $5.9299 | $7.4889 | +145.04% |
| May, 2029 | $6.3814 | $5.4602 | $7.4411 | +163.69% |
| June, 2029 | $6.1126 | $5.812 | $7.1619 | +152.59% |
| July, 2029 | $7.1539 | $5.5933 | $7.7539 | +195.61% |
| August, 2029 | $6.2454 | $5.7051 | $7.4942 | +158.08% |
| September, 2029 | $6.4467 | $5.843 | $6.568 | +166.39% |
| October, 2029 | $5.8682 | $4.9876 | $6.4373 | +142.49% |
| November, 2029 | $5.9694 | $5.8481 | $6.2368 | +146.67% |
| December, 2029 | $6.4601 | $5.9597 | $6.74 | +166.95% |
Collplant Biotechnologies Ltd Stock (CLGN) Price Forecast for 2030
Collplant Biotechnologies Ltd Stock (CLGN) is expected to reach an average price of $10.33 in 2030, with a high forecast of $15.94 and a low forecast of $4.718. This signifies an +326.78% surge from the last price of $2.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.0931 | $5.6919 | $7.3125 | +193.10% |
| February, 2030 | $5.7656 | $5.1943 | $7.0837 | +138.25% |
| March, 2030 | $4.718 | $4.718 | $5.9662 | +94.96% |
| April, 2030 | $5.5705 | $4.7186 | $6.0499 | +130.19% |
| May, 2030 | $5.4036 | $5.2511 | $5.5711 | +123.29% |
| June, 2030 | $5.916 | $5.4248 | $6.076 | +144.46% |
| July, 2030 | $6.2291 | $5.4279 | $6.5291 | +157.40% |
| August, 2030 | $6.9625 | $6.1504 | $7.1377 | +187.71% |
| September, 2030 | $9.6741 | $6.9822 | $10.34 | +299.75% |
| October, 2030 | $12.39 | $9.6847 | $13.44 | +411.87% |
| November, 2030 | $11.42 | $10.49 | $15.94 | +371.88% |
| December, 2030 | $10.03 | $9.3921 | $11.69 | +314.26% |
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):